Vanda Pharmaceuticals Inc (NASDAQ: VNDA) open the trading on Wednesday, with a bit cautious approach as it glided -1.51% to $4.56, before settling in for the price of $4.63 at the close. Taking a more long-term approach, VNDA posted a 52-week range of $3.30-$7.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 1.11% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -37.98%. This publicly-traded company’s shares outstanding now amounts to $57.53 million, simultaneously with a float of $54.51 million. The organization now has a market capitalization sitting at $262.38 million. At the time of writing, stock’s 50-day Moving Average stood at $4.26, while the 200-day Moving Average is $4.49.
Vanda Pharmaceuticals Inc (VNDA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vanda Pharmaceuticals Inc’s current insider ownership accounts for 5.26%, in contrast to 88.37% institutional ownership. According to the most recent insider trade that took place on Mar 05 ’24, this organization’s President and CEO sold 24,288 shares at the rate of 4.13, making the entire transaction reach 100,273 in total value, affecting insider ownership by 1,871,730. Preceding that transaction, on Mar 05 ’24, Company’s SVP, Chief Marketing Officer sold 9,229 for 4.21, making the whole transaction’s value amount to 38,830. This particular insider is now the holder of 129,789 in total.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Let’s observe the current performance indicators for Vanda Pharmaceuticals Inc (VNDA). It’s Quick Ratio in the last reported quarter now stands at 4.92. The Stock has managed to achieve an average true range (ATR) of 0.34. Alongside those numbers, its PE Ratio stands at $104.35, and its Beta score is 0.73. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.36. Similarly, its price to free cash flow for trailing twelve months is now 21.13.
In the same vein, VNDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.04.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
[Vanda Pharmaceuticals Inc, VNDA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 40.26% While, its Average True Range was 0.36.
Raw Stochastic average of Vanda Pharmaceuticals Inc (VNDA) in the period of the previous 100 days is set at 42.80%, which indicates a major rise in contrast to 34.12% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 122.16% that was higher than 77.85% volatility it exhibited in the past 100-days period.
